Repligen (RGEN) Non-Current Assets (2011 - 2026)
Repligen (RGEN) posted quarterly Non-Current Assets of $1.7 billion for Q2 2026, down 5.16% year-over-year from $1.8 billion in Q2 2025, and down 1.12% quarter-over-quarter from $1.8 billion in Q1 2026.
Repligen (RGEN) Non-Current Assets (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Non-Current Assets for 16 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets fell 5.16% year-over-year to $1.7 billion; the TTM figure through Jun 2026 stood at $5.1 billion (up 173.94% YoY), while the FY2025 annual figure was $1.8 billion, up 2.76% from the prior year.
- Non-Current Assets slipped to $1.7 billion in Q2 2026 per RGEN's latest filing, from $1.8 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.8 billion in Q2 2025 and bottomed at $1.4 billion in Q1 2022.
- Historically, Non-Current Assets has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets soared 43.76% — and 2026, when it dropped 5.16%.
- Repligen's Non-Current Assets stood at $1.5 billion in 2022, then grew by 12.15% to $1.7 billion in 2023, then gained by 2.55% to $1.8 billion in 2024, then rose by 2.76% to $1.8 billion in 2025, then declined by 3.46% to $1.7 billion in 2026.
- Business Quant data shows RGEN's Non-Current Assets at $1.7 billion in Q2 2026, $1.8 billion in Q1 2026, and $1.8 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 1.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.75 Bn |
| Mar 31, 2026 | 1.77 Bn |
| Dec 31, 2025 | 1.81 Bn |
| Sep 30, 2025 | 1.83 Bn |
| Jun 30, 2025 | 1.84 Bn |
| Mar 31, 2025 | 1.82 Bn |
| Dec 31, 2024 | 1.76 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.71 Bn |
| Mar 31, 2024 | 1.72 Bn |
| Dec 31, 2023 | 1.72 Bn |
| Sep 30, 2023 | 1.54 Bn |
| Jun 30, 2023 | 1.56 Bn |
| Mar 31, 2023 | 1.53 Bn |
| Dec 31, 2022 | 1.53 Bn |
| Sep 30, 2022 | 1.51 Bn |
| Jun 30, 2022 | 1.47 Bn |
| Mar 31, 2022 | 1.44 Bn |
| Dec 31, 2021 | 1.43 Bn |
| Sep 30, 2021 | 1.33 Bn |